Intuitive Surgical, Inc. $ISRG Stock: Seilern Investment Management Ltd Grows Holdings

Seilern Investment Management Ltd boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 133,918 shares of the medical equipment provider’s stock after acquiring an additional 18,223 shares during the period. Intuitive Surgical accounts for about 6.8% of Seilern Investment Management Ltd’s portfolio, making the stock its 3rd biggest position. Seilern Investment Management Ltd’s holdings in Intuitive Surgical were worth $54,455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Motiv8 Investments LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $34,000. Main Street Group LTD bought a new position in Intuitive Surgical in the 1st quarter valued at about $30,000. North Point Portfolio Managers Corp OH bought a new position in Intuitive Surgical in the 3rd quarter valued at about $27,000. Vermillion Wealth Management Inc. raised its position in shares of Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 25 shares in the last quarter. Finally, Evergreen Advisors LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $35,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 1.5%

NASDAQ ISRG traded down $6.43 on Tuesday, hitting $421.21. 699,164 shares of the company were exchanged, compared to its average volume of 2,407,277. The stock has a fifty day moving average of $387.41 and a 200-day moving average of $410.47. The company has a market cap of $148.80 billion, a PE ratio of 48.24, a PEG ratio of 3.20 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.81 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on ISRG shares. UBS Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Tuesday. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Raymond James Financial reiterated an “outperform” rating and issued a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Finally, Mizuho set a $415.00 target price on shares of Intuitive Surgical in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $498.83.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the transaction, the executive vice president directly owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of the stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the transaction, the vice president directly owned 1,026 shares of the company’s stock, valued at $384,175.44. This represents a 51.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 12,370 shares of company stock worth $4,891,989. 0.60% of the stock is owned by company insiders.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS reiterated a Buy rating and maintained a $500 price target, citing Intuitive Surgical’s long-term growth runway for robotic-assisted surgery. Intuitive Surgical Buy Rating Reiterated on Long-Term Robotic Growth Runway
• Positive Sentiment: Erste Group Bank modestly raised its FY2027 earnings-per-share forecast to $10.09 from $10.06. The new estimate is also above the current consensus forecast of $8.87 for the current year, signaling improving expectations for future profitability.
• Positive Sentiment: Zacks identified ISRG as a sales-growth stock to consider as third-quarter earnings season begins, highlighting its strong revenue growth, cash generation and business momentum. 3 Sales Growth Stocks to Buy as Q3 Earnings Get Underway
• Neutral Sentiment: Investors have been searching heavily for Intuitive Surgical, increasing the stock’s visibility ahead of earnings but not necessarily indicating a change in fundamentals. Investors Heavily Search Intuitive Surgical
• Neutral Sentiment: Intuitive Surgical is expected to report quarterly earnings, making the upcoming results, procedure growth and management outlook important near-term catalysts. Intuitive Surgical Expected to Post Quarterly Earnings
• Negative Sentiment: BTIG lowered its price target to $454 from $469, although it retained a Buy rating. The cut suggests more limited near-term upside and may weigh on sentiment despite continued confidence in the company. Intuitive Surgical Stock Price Target Lowered at BTIG Research

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.